Peptides DB
Research-centric peptide and protocol reference hub
Study 2 of 4Ipamorelin literaturePubMed · Observational · Preclinical2024

The influence of ghrelin agonist ipamorelin acetate on the hypothalamic-pituitary-testicular axis in a cichlid fish, Oreochromis mossambicus.

Ipamorelin acetate significantly increased food intake and various spermatocyte stages in tilapia, but the implications for broader applications remain unclear.

Read at PubMedAdd to compare

Where it sits

this study against the rest of the ipamorelin corpus
1
Preclinical
3
Observational · this one
0
Open-label
0
Randomised
0
Reviews

Summary and findings

This study measured the effects of ipamorelin acetate (IPA) on the reproductive axis in the cichlid fish Oreochromis mossambicus, using doses of 5 or 30 µg over 21 days. Significant increases in food intake and various spermatocyte stages were observed, along with elevated luteinizing hormone (LH) and 11-ketotestosterone (11-KT) levels compared to controls. No significant differences were noted in GnRH-immunoreactive fibers across groups.

How much of this paper we could read: partial text (0.60). We had some abstract detail. Check the source for anything decisive. What this means →
Significant elevation in serum LH and 11-KT concentrations with both 5 and 30 µg IPA compared to control.Preclinical2024

Abstract

The authors’ words, as PubMed supplied them

Ghrelin, a peptide found in the brain and gut, is predicted to play a significant role in the control of various physiological systems in fish. The objective of this study was to examine the impact of ipamorelin acetate (IPA), a ghrelin agonist, on the reproductive axis of the tilapia Oreochromis mossambicus. The administration of either 5 or 30 µg of IPA for 21 days led to a significant and dose-dependent rise in food intake concomitant with a significant increase in the numbers of primary spermatocytes, secondary spermatocytes, and early spermatids compared to the control group. There was a significant rise in the number of late spermatids, as well as the areas of the lobule and lumen, in fish treated with 30 µg of IPA, compared to the control group. Moreover, there was no significant difference in the percentage of gonadotropin-releasing hormone (GnRH)-immunoreactive fibres in the hypothalamus and anterior pituitary gland across different groups. However, a significant elevation in the expression of androgen receptor protein was observed in fish treated with 30 µg of IPA. Furthermore, the concentrations of luteinizing hormone (LH) and 11-ketotestosterone (11-KT) in the serum of fish treated with either 5 or 30 µg of IPA were significantly elevated in comparison to the control group. Collectively, these findings suggest that the administration of ghrelin enhances the development of germ cells during the meiosis-I phase and that this effect might be mediated via the stimulation of 11-KT and androgen receptors at the testicular level and LH at the pituitary level in the tilapia.

Background

The paper investigates the role of ghrelin and its agonists, such as ipamorelin, in regulating the hypothalamic-pituitary-testicular axis, a critical pathway for reproductive function. Prior studies have established the importance of this axis in various species, but the specific effects of ghrelin agonists in fish have not been thoroughly explored. Understanding these mechanisms in fish could provide broader insights into endocrine functions across species.

Methods

The study utilized cichlid fish (Oreochromis mossambicus) to assess the effects of ipamorelin acetate on reproductive hormone regulation. The specific number of subjects (n), dosing regimen, duration of treatment, and routes of administration were not reported in the abstract. Primary and secondary outcomes related to hormonal changes were likely measured, but details were not provided.

Results

Not reported in abstract.

Interpretation

Without specific results, it is difficult to compare findings to existing literature on ghrelin agonists and reproductive physiology. The absence of reported effect sizes and statistical significance limits the ability to draw conclusions about the clinical relevance of the findings. Additionally, the use of a non-mammalian model may introduce confounding factors that affect the generalizability of the results to human health.

Key findings

  • Not reported in abstract.

Limitations

  • Not reported in abstract.
  • Non-mammalian model may limit applicability to humans.
  • Specific dosing and outcomes not detailed.

Elsewhere in the Ipamorelin corpus

DSemantic Scholar search for IpamorelinSemanticScholar · 2010CAttenuation of Visceral and Somatic Nociception by Ghrelin Mimetics.PubMed · 2020 · Not reported in abstract.AnimalCThe growth hormone secretagogue receptor 1a agonists, anamorelin and ipamorelin, inhibit cisplatin-induced weight loss in ferrets: Anamorelin also exhibits anti-emetic effects via a central mechanism.PubMed · 2024 · Anamorelin reduced cisplatin-induced acute emesis by 60% following intracerebroventricular administration.Animal